Literature DB >> 23820448

Can we predict a favourable response to Ketogenic Diet Therapies for drug-resistant epilepsy?

Natasha E Schoeler1, J Helen Cross, Josemir W Sander, Sanjay M Sisodiya.   

Abstract

Ketogenic Dietary Therapies (KDT) are an effective treatment option for some people with drug-resistant epilepsy. They are, however, resource-intensive and can cause adverse side effects. Predictors of response would improve the selection process and perhaps further our understanding of the mechanisms behind dietary treatments for epilepsy. We conducted a literature review to identify factors that may influence response to KDT. We found no strong evidence that there are any specific factors that affect response. Gender and intellectual status do not seem to affect response; evidence is inconsistent for all other factors. Experimental studies may point us in the right direction for future work.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Dietary treatments; Outcomes; Review

Mesh:

Substances:

Year:  2013        PMID: 23820448     DOI: 10.1016/j.eplepsyres.2013.06.002

Source DB:  PubMed          Journal:  Epilepsy Res        ISSN: 0920-1211            Impact factor:   3.045


  9 in total

1.  Ketogenic diet-induced extension of longevity in epileptic Kcna1-null mice is influenced by gender and age at treatment onset.

Authors:  Kyoung-Chul Chun; Shun-Chieh Ma; Hyoungil Oh; Jong M Rho; Do Young Kim
Journal:  Epilepsy Res       Date:  2017-11-21       Impact factor: 3.045

2.  Anticonvulsant Effect of Time-Restricted Feeding in a Pilocarpine-Induced Seizure Model: Metabolic and Epigenetic Implications.

Authors:  Jorge Landgrave-Gómez; Octavio Fabián Mercado-Gómez; Mario Vázquez-García; Víctor Rodríguez-Molina; Laura Córdova-Dávalos; Virginia Arriaga-Ávila; Alfredo Miranda-Martínez; Rosalinda Guevara-Guzmán
Journal:  Front Cell Neurosci       Date:  2016-01-28       Impact factor: 5.505

3.  The Efficacy of Ketogenic Diet for Specific Genetic Mutation in Developmental and Epileptic Encephalopathy.

Authors:  Ara Ko; Da E Jung; Se H Kim; Hoon-Chul Kang; Joon S Lee; Seung T Lee; Jong R Choi; Heung D Kim
Journal:  Front Neurol       Date:  2018-07-16       Impact factor: 4.003

4.  Efficacy of Ketogenic Diet for Infantile Spasms in Chinese Patients With or Without Monogenic Etiology.

Authors:  Jun Wang; Jie Zhang; Ying Yang; Kai Gao; Ye Wu; Yuehua Zhang; Yuwu Jiang
Journal:  Front Pediatr       Date:  2022-03-17       Impact factor: 3.418

5.  Variants in KCNJ11 and BAD do not predict response to ketogenic dietary therapies for epilepsy.

Authors:  Natasha E Schoeler; Costin Leu; Jon White; Vincent Plagnol; Sian Ellard; Mar Matarin; Gary Yellen; Elizabeth A Thiele; Mark Mackay; Jacinta M McMahon; Ingrid E Scheffer; Josemir W Sander; J Helen Cross; Sanjay M Sisodiya
Journal:  Epilepsy Res       Date:  2015-10-24       Impact factor: 3.045

6.  Genome-wide association study: Exploring the genetic basis for responsiveness to ketogenic dietary therapies for drug-resistant epilepsy.

Authors:  Natasha E Schoeler; Costin Leu; Simona Balestrini; Jonathan M Mudge; Charles A Steward; Adam Frankish; Mary-Anne Leung; Mark Mackay; Ingrid Scheffer; Ruth Williams; Josemir W Sander; J Helen Cross; Sanjay M Sisodiya
Journal:  Epilepsia       Date:  2018-07-16       Impact factor: 5.864

7.  Graph Theory-Based Electroencephalographic Connectivity and Its Association with Ketogenic Diet Effectiveness in Epileptic Children.

Authors:  Ting-Yu Su; Pi-Lien Hung; Chien Chen; Ying-Jui Lin; Syu-Jyun Peng
Journal:  Nutrients       Date:  2021-06-25       Impact factor: 5.717

8.  K.Vita: a feasibility study of a blend of medium chain triglycerides to manage drug-resistant epilepsy.

Authors:  Natasha E Schoeler; Michael Orford; Umesh Vivekananda; Zoe Simpson; Baheerathi Van de Bor; Hannah Smith; Simona Balestrini; Tricia Rutherford; Erika Brennan; James McKenna; Bridget Lambert; Tom Barker; Richard Jackson; Robin S B Williams; Sanjay M Sisodiya; Simon Eaton; Simon J R Heales; J Helen Cross; Matthew C Walker
Journal:  Brain Commun       Date:  2021-07-23

Review 9.  Metabolism-based therapies for epilepsy: new directions for future cures.

Authors:  Mackenzie Cervenka; Juan M Pascual; Jong M Rho; Elizabeth Thiele; Gary Yellen; Vicky Whittemore; Adam L Hartman
Journal:  Ann Clin Transl Neurol       Date:  2021-07-11       Impact factor: 4.511

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.